SCIEX and the Bioprocessing Technology Institute Announce Partnership
The partnership will focus on the identification and analysis of host-cell proteins in biologics.
High-throughput methods of identifying host-cell proteins in biotherapeutics will be the focus of a new partnership between SCIEX and Singapore’s Bioprocessing Technology Institute (BTI), according to a press release from SCIEX on Jan. 26, 2016.
Under the terms of the agreement, SCIEX with provide BTI with analytical mass spectrometry instruments-including the company’s TripleTOF 6600 system, Nano LC system, and proprietary software-to help BTI advance its work on the analysis of contaminating host-cell proteins in biologic drugs. In exchange, BTI will provide SCIEX with data and validation results from their studies.
Singapore’s BTI has been expanding its presence in the biologic space since early 2015. In May 2015, BTI’s Agency for Science, Technology and Research (A*STAR) division partnered with Visterra to develop a neutralizing antibody for the treatment of dengue fever. In July 2015, BTI announced a partnership with Agilent to develop new methods of glycan analysis for large-molecule protein therapeutics.
Source: SCIEX
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
